The evidence, therefore, suggests that in conditions of hyperleptinemia and hyperresistinemia, such as overweight, obesity or metabolic syndrome, the potential for central crosstalk between leptin and resistin is high and the result could contribute to worsened metabolic function and cardiovascular dysfunction (Figure 4). The gene discussed is RETN; the disease is metabolic syndrome.